EP2271310A1 - Cosmétiques contenant des extraits d'herbes de ciste - Google Patents

Cosmétiques contenant des extraits d'herbes de ciste

Info

Publication number
EP2271310A1
EP2271310A1 EP09741957A EP09741957A EP2271310A1 EP 2271310 A1 EP2271310 A1 EP 2271310A1 EP 09741957 A EP09741957 A EP 09741957A EP 09741957 A EP09741957 A EP 09741957A EP 2271310 A1 EP2271310 A1 EP 2271310A1
Authority
EP
European Patent Office
Prior art keywords
skin
care
formulations according
hair
care formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09741957A
Other languages
German (de)
English (en)
Inventor
Yvonne Schiemann
Mike Farwick
Heike Blasko-Begoihn
Peter Lersch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Evonik Goldschmidt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Goldschmidt GmbH filed Critical Evonik Goldschmidt GmbH
Publication of EP2271310A1 publication Critical patent/EP2271310A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Definitions

  • the dry matter content of the remaining extract is preferably more than 50% (m / m).
  • catechin hydrate 30 mg are dissolved in 10% ethanol and then diluted to 50 ml with the same solvent (stock solution). 7.0 ml or 4.0 ml (depending on the polyphenol concentration of the substance to be examined) of this stock solution are diluted to 10 ml with 10% ethanol this solution serves as a reference solution for the preparation of a calibration line.
  • the extract to be determined is dissolved in ethanol (96%) and made up to a defined volume (eg 250 ml) with water. 250 ⁇ l of this sample or 250 ⁇ l reference substance ((+ -) - catechin hydrate (Sigma, Art. C 1788, Ch.
  • Hydrotropes (or polyols),
  • methyl esters and isopropyl esters of Fatty acids having 12 to 22 C atoms such as, for example, methyl laurate, methyl stearate, methyl oleate, methyl erucate, isopropyl palmitate, isopropyl myristate, isopropyl stearate, isopropyl oleate.
  • emollients and oil component are longer chain triglycerides, ie, triple esters of glycerol with three acid molecules, at least one of which is longer chain.
  • fatty acid triglycerides are mentioned; as such, for example, natural, vegetable oils, eg olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil,
  • Polysiloxane-polyalkyl-polyether copolymers or corresponding derivatives such as e.g. Lauryl or cetyl dimethicone copolyols, in particular cetyl PEG / PPG-10/1 dimethicone (ABIL® EM 90 (Evonik)),
  • inorganic thickeners can be used, such as silica, alumina or phyllosilicates (eg hectorite, laponite, saponite). These inorganic oil phase thickeners may be hydrophobically modified.
  • silica, alumina or phyllosilicates eg hectorite, laponite, saponite.
  • phyllosilicates eg hectorite, laponite, saponite
  • These inorganic oil phase thickeners may be hydrophobically modified.
  • aerosils, phyllosilicates and / or metal salts of fatty acids, such as zinc stearate be used.
  • organic substances which are able to absorb ultraviolet rays and the absorbed energy in the form of longer wavelengths can be used as the UV light protection filter
  • UVB filters can be oil-soluble or water-soluble.
  • oil-soluble UVB sunscreens e.g. to call :
  • esters of salicylic acid e.g. Salicylic acid 2-ethylhexyl ester, salicylic acid
  • Dyes which may be used are those which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Kosmetician Anlagenrbesch" of the Dye Commission of Irish Anlagenstechnik, Verlag Chemie, Weinheim, 1984, pp. 81 to 106 Concentrations of 0.001 to 0.1 wt .-%, based on the total mixture used.
  • UVB radiation can penetrate into deep skin layers. Thus, it can not only react with the epidermal cells, but also with the fibroblasts of the dermis and there trigger the formation of radicals.
  • the short-wave UVB radiation is largely absorbed already in the epidermis and mainly changes DNA and proteins in epidermal keratinocytes and Langerhans cells. To a lesser extent, UVB radiation also stimulates the formation of radicals by hydrolysis. Thus, lipids, proteins and nucleic acids are damaged by different UV wavelengths in different layers. If human hair is to be dyed permanently, only oxidizing hair dyeing processes can be considered in practice.
  • Another object of the invention is therefore the use of the care formulations according to the invention for the treatment and / or prophylaxis of oxidative stress induced aging and / or hair damage.
  • the subject of the invention is the use of the care formulations according to the invention for reducing the caused by environmental toxins or UV-induced hair and / or skin damage.
  • Lactate dehydrogenase release The appearance of LDH in the cell culture medium is a sure sign of damage to the cytoplasmic membrane of the cells and thus damage to the epidermal cell layer. Furthermore, it is known that an escape of this enzyme represents the "point of no return" for the cell, and thus indicates an irreversibility of the damage.
  • the First-Strand cDNA Synthesis Kit for RT-PCR performs reverse transcription.
  • 100 ng RNA of the samples are mixed with 1 ⁇ L random hexamer (50 ⁇ M) and 1 ⁇ L DEPC water and brought to a volume of 10 ⁇ L with water.
  • This solution is at 65 0 C for five Incubated for a few minutes and then stored for one minute on ice.
  • water is used as a blank in all investigations.
  • ⁇ l_ to each solution 10 cDNA Synthesis mix added, mixed and the solution heated for 10 minutes at 25 0 C, 50 minutes at 50 0 C and 5 minutes at 85 0 C and then stored on ice.
  • 1 ⁇ L RNase H is added and incubated at 37 0 C for 20 minutes. The solution can then be frozen at -80 0 C or used for PCR measurement.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne l'utilisation d'un extrait de ciste fabriqué au moyen d'un nouveau procédé en tant qu'agent actif pour le soin de parties du corps de l'homme ou de l'animal. L'invention concerne également des formulations de soin et l'utilisation de ces formulations de soin.
EP09741957A 2008-05-06 2009-04-06 Cosmétiques contenant des extraits d'herbes de ciste Withdrawn EP2271310A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008022392A DE102008022392A1 (de) 2008-05-06 2008-05-06 Kosmetika enthaltend Zistrosenkraut-Extrakte
PCT/EP2009/054068 WO2009135739A1 (fr) 2008-05-06 2009-04-06 Cosmétiques contenant des extraits d'herbes de ciste

Publications (1)

Publication Number Publication Date
EP2271310A1 true EP2271310A1 (fr) 2011-01-12

Family

ID=40943516

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09741957A Withdrawn EP2271310A1 (fr) 2008-05-06 2009-04-06 Cosmétiques contenant des extraits d'herbes de ciste

Country Status (6)

Country Link
US (1) US20110052522A1 (fr)
EP (1) EP2271310A1 (fr)
JP (1) JP2011519887A (fr)
CN (1) CN102014865A (fr)
DE (1) DE102008022392A1 (fr)
WO (1) WO2009135739A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102274149B (zh) * 2011-08-13 2013-09-18 成都绿迪科技有限公司 一种用于处理头发和头皮的制剂及其使用方法
KR102062820B1 (ko) * 2013-03-25 2020-02-20 로레알 고융점 왁스 및 실리카 에어로겔을 포함하는 고체 무수 조성물
UA120165C2 (uk) 2013-07-25 2019-10-25 Олтріа Клайєнт Сервісиз Ллк Електронний виріб для вейпінгу
CN103393572B (zh) * 2013-08-06 2014-09-17 珀莱雅化妆品股份有限公司 具有抗老化功效的深亚微米粒乳液的制备方法
CN103622900B (zh) * 2013-09-05 2016-08-17 澳宝化妆品（惠州）有限公司 一种修复肌肤的油包水保湿护肤霜
JP6305157B2 (ja) * 2014-03-28 2018-04-04 株式会社コーセー 組成物、化粧料
EP3339387B1 (fr) 2016-12-22 2020-06-24 Evonik Operations GmbH Liaisons à base d'adduits avec des isocyanates pour compositions de revêtement
US20180296460A1 (en) * 2017-04-13 2018-10-18 Eos Products, Llc Lip product formulation, applicator, and method for making same
TR202008345A2 (tr) * 2020-05-29 2021-12-21 Anadolu Ueniversitesi Cistus creticus ekstresi?nden elde edi?len jel formu?lasyonlari ve bu formu?lasyonlarin hemostati?k ajan olarak kullanimi
CN115671002B (zh) * 2022-11-23 2024-02-20 广州睿森生物科技有限公司 一种抗皱滋养祛痘组合物及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1165574B (de) 1960-08-08 1964-03-19 Dehydag Gmbh Verfahren zur Herstellung von als Emulgiermittel fuer Salbengrundlagen dienenden Mischestern
DE3740186A1 (de) 1987-06-24 1989-01-05 Beiersdorf Ag Desodorierende und antimikrobielle zusammensetzung zur verwendung in kosmetischen oder topischen zubereitungen
DE3938140A1 (de) 1989-11-16 1991-08-08 Beiersdorf Ag Desodorierende kosmetische mittel
DE4009347A1 (de) 1990-03-23 1991-09-26 Beiersdorf Ag Desodorierende kosmetische mittel
JPH05198768A (ja) 1992-01-21 1993-08-06 Mitsubishi Electric Corp 半導体記憶装置およびその製造方法
DE4204321A1 (de) 1992-02-13 1993-08-19 Beiersdorf Ag Verfahren zur isolierung und reinigung von fettsaeuren und hydroxyfettsaeuren und verwendungen von hydroxyfettsaeuren sowie zubereitungen, die sie enthalten
DE4229707A1 (de) 1992-09-05 1994-03-10 Beiersdorf Ag Germicide Wirkstoffkombinationen
DE4229737C2 (de) 1992-09-05 1996-04-25 Beiersdorf Ag Desodorierende kosmetische Mittel mit einem Gehalt an Fettsäuren
DE4237081C2 (de) 1992-11-03 1996-05-09 Beiersdorf Ag Verwendung von Di- oder Triglycerinestern als Deowirkstoffe
DE4309372C2 (de) 1993-03-23 1997-08-21 Beiersdorf Ag Kosmetische Desodorantien, enthaltend Gemische aus Wollwachssäuren oder Wollwachssäurekomponenten und Fettsäurepartialglyceriden unverzweigter Fettsäuren
DE4324219C2 (de) 1993-07-20 1995-08-10 Beiersdorf Ag Desodorierende Wirkstoffkombinationen auf der Basis von alpha, omega-Alkandicarbonsäuren und Wollwachssäuren
JP4299374B2 (ja) * 1996-10-08 2009-07-22 高砂香料工業株式会社 細胞賦活剤及びその応用
JP3557095B2 (ja) * 1998-04-20 2004-08-25 高砂香料工業株式会社 メラニン産生抑制剤
DE19855934A1 (de) 1998-12-04 2000-06-08 Beiersdorf Ag Verwendung von Betainen als Antitranspirantien
ES2266251T3 (es) * 2000-08-31 2007-03-01 Phenolics, Llc Metodo eficaz para producir composiciones enriquecidas con antocianinas.
DE10133203A1 (de) * 2001-07-07 2003-01-16 Beiersdorf Ag Catechine oder Extrakte von grünem Tee enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
JP4091824B2 (ja) * 2002-02-05 2008-05-28 株式会社コーセー 皮膚外用剤
EP1570839B1 (fr) * 2002-11-07 2008-07-09 Kosé Corporation Composition pour une preparation destinee a un usage externe sur la peau, et methode d'utilisation s'y rapportant
JP4574959B2 (ja) * 2003-06-02 2010-11-04 ポーラ化成工業株式会社 α−ＭＳＨ抑制用の皮膚外用剤
JP2005008574A (ja) * 2003-06-19 2005-01-13 Takasago Internatl Corp コラーゲン産生促進剤
DE102005026061A1 (de) * 2005-06-07 2006-12-28 Goldschmidt Gmbh Depolymerisiertes Scleroglucan zur Regulierung und Verbesserung des Feuchtigkeitsgehaltes der Haut
DE102005026069A1 (de) * 2005-06-07 2006-12-14 Goldschmidt Gmbh Topische kosmetische Formulierungen zur Regulierung und Verbesserung des Feuchtigkeitsgehalts der Haut
DE602005004139T2 (de) * 2005-06-30 2009-01-02 Evonik Goldschmidt Gmbh Verwendung von Salicyloyl-Sphingoidbase zur Behandlung oder Verhinderung von Cellilitis
JP2008088097A (ja) * 2006-09-29 2008-04-17 Katakura Chikkarin Co Ltd 抗炎症剤
DE102006047529A1 (de) * 2006-10-07 2008-04-10 Evonik Goldschmidt Gmbh Oligopeptide enthaltende dermatologische Zusammensetzungen zur Steigerung der Hautempfindlichkeit und der neuronalen Reizwahrnehmung
CN101511333B (zh) * 2006-10-13 2011-11-30 赢创戈尔德施米特有限公司 皮肤处理组合物
DE102007049612A1 (de) * 2007-10-17 2009-06-10 Evonik Goldschmidt Gmbh Bioaktive Zusammensetzung für kosmetische Anwendungen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2009135739A1 *

Also Published As

Publication number Publication date
WO2009135739A1 (fr) 2009-11-12
CN102014865A (zh) 2011-04-13
JP2011519887A (ja) 2011-07-14
DE102008022392A1 (de) 2009-11-12
US20110052522A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
EP2271310A1 (fr) Cosmétiques contenant des extraits d'herbes de ciste
EP2057995B1 (fr) Composition bioactive pour applications cosmétiques
EP1347768B1 (fr) Preparations cosmetiques et/ou dermopharmaceutiques contenant des extraits de feuilles de la plante i argania spinosa /i
EP1313497B1 (fr) Utilisation d'extraits de la plante cassia alata
EP1351662A1 (fr) Preparations cosmetiques et/ou pharmaceutiques
WO2003059368A1 (fr) Principes actifs a utiliser en tant que produits cosmetiques et/ou pharmaceutiques, produits par la fermentation de composants et/ou d'extraits de vegetaux
EP1658088A1 (fr) Extraits de plantes a effet prebiotique
EP1281392A1 (fr) Compositions cosmétiques et/ou pharmaceutiques contenant des extraits de plantes
EP1257253A2 (fr) Preparations cosmetiques contenant des extraits vegetaux
DE102008042149A1 (de) Kosmetische und dermatologische Formulierungen enthaltend Phenoxyalkylester
WO2002080949A1 (fr) Utilisation d'extraits de la plante litchi chinensis sonn.
WO2002045729A1 (fr) Preparations cosmetiques ou dermopharmaceutiques contenant des proteines natives de la plante argania spinosa
WO2009024374A2 (fr) Formulations contenant de nouveaux composés dipolaires ioniques et leur utilisation
EP1310261A1 (fr) Utilisation d'un extrait de Vigna aconitifolia dans une composition cosmétique et/ou dermopharmaceutique
EP1539128B1 (fr) Utilisation de substances pour proteger la peau
EP1314420A1 (fr) Compositions contre le vieillissement
DE10218476A1 (de) Zubereitungen mit Lignanen
DE202021004361U1 (de) Multifunktionelle Mischungen, die mehrere (Bio)-Alkandiole enthalten
DE102008052341A1 (de) Verwendung von Pflegeformulierungen enthaltend einen Extrakt aus Mangostan
EP1292278B1 (fr) Preparations renfermant un extrait de plantes pistia stratiotes
EP3389621B1 (fr) Émulsions contenant des filtres uv et des carnosines
DE19962345B4 (de) Kosmetische Mittel mit Pflanzenextrakten aus den Samenhäutchen von Arachis hypogaea L. und Verwendung der Pflanzenextrakte
WO2008028585A2 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2002069911A2 (fr) Combinaisons de principes actifs, reunissant de l'acide $g(a)-lipoique et des bioquinones
DE10127432A1 (de) Wirkstoffkombination zur Verhinderung unerwünschter Hautpigmentierung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20101007

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EVONIK DEGUSSA GMBH

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20151103